Galit Zuckerman

Founder & CEO of Medasense Biometrics Ltd. Medasense is a medical device company that has developed a non-invasive platform technology enabling objective assessment of pain in sedated and in conscious patients. Better assessment of pain can contribute to improved clinical outcomes and a reduction in costs associated with non-optimal pain management. Medasense was founded upon discovering that while advanced algorithms are used frequently in many different industries like semiconductors, communication, etc., the discipline of medicine and specifically pain is still left behind. At present, pain is still assessed through a patients subjective self-reporting or a review of a patients vital signs by clinicians where they are unable to communicate (under sedation, mentally ill, etc.). Today, Medasense is close to commercialization of our patented pain monitoring technology which is based on state-of-the-art analysis of multiple physiological signals. Our first commercial device is designed to provide highly accurate pain level assessment in patients under general anesthesia. To learn more about the Medasense commercial opportunity and technology, please message me and Ill get back to you as soon as possible. Many thanks, Galit www.medasense.com